Delivery Order SPE2DX15D1902-SPE2DX24FC2CC
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,683.52 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide moxifloxacin hydrochloride and other pharmaceutical and medical supplies. The contract has a completion date of February 24, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA with a potential value of up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,514.78 firm fixed price delivery order contract to provide the pharmaceutical product moxifloxacin hydrochloride. The award has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,103.30 contract is for the delivery of the pharmaceutical product Moxifloxacin Hydrochl by the completion date of December 26, 2023. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceuticals and medical supplies to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,121.02 contract is for the delivery of MOXIFLOXACIN 400MG 12S, a pharmaceutical product, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is not designated as a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide moxifloxacin hydrochloride and other pharmaceutical products and medical supplies. The contract has a potential value of $6,487.35 and a completion date of February 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOXIFLOXACIN HYDROCHL pharmaceuticals and related medical supplies. The $8,103.30 contract has a completion date of December 26, 2023 and was awarded on December 22, 2023. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MOXIFLOXACIN HYDROCHL pharmaceuticals and related medical supplies. The $7,732.39 award has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,054.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical drug moxifloxacin hydrochloride and has a completion date of July 26, 2023. Amerisourcebergen Drug Corp has received numerous similar contract awards from DLA to provide...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX24FC5KQ) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of moxifloxacin hydrochloride and other pharmaceutical products and medical supplies. The $1,249.50 ceiling value contract has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,514.78 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide moxifloxacin hydrochloride, a pharmaceutical product. The delivery order has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary...
- SPE2DX15D1902Indefinite Delivery Contract
- SPE2DX15D1902-SPE2DX24FC2CCDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,723.59 contract is for the supply of moxifloxacin hydrochloride, a pharmaceutical product. The contract has a completion date of February 23, 2024 and was awarded on December 22, 2023. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($118) | 2/23/24 | |
| Not listed | Not listed | $7.8k | 12/22/23 |